Texas Permanent School Fund’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $7.1M | Buy |
+65,965
| New | +$7.1M | 0.07% | 251 |
|
|
2024
Q3 | – | Sell |
-80,235
| Closed | -$11M | – | 899 |
|
|
2024
Q2 | $11M | Sell |
80,235
-6,852
| -8% | -$943K | 0.1% | 163 |
|
|
2024
Q1 | $12M | Buy |
87,087
+2,211
| +3% | +$305K | 0.09% | 178 |
|
|
2023
Q4 | $11.2M | Buy |
84,876
+1,941
| +2% | +$256K | 0.1% | 170 |
|
|
2023
Q3 | $9.33M | Sell |
82,935
-2,978
| -3% | -$335K | 0.09% | 182 |
|
|
2023
Q2 | $8.1M | Sell |
85,913
-707
| -0.8% | -$66.7K | 0.08% | 239 |
|
|
2023
Q1 | $8.77M | Buy |
86,620
+21,990
| +34% | +$2.23M | 0.09% | 199 |
|
|
2022
Q4 | $7.72M | Sell |
64,630
-4,155
| -6% | -$496K | 0.12% | 147 |
|
|
2022
Q3 | $7.31M | Sell |
68,785
-296
| -0.4% | -$31.4K | 0.12% | 140 |
|
|
2022
Q2 | $6.73M | Buy |
69,081
+1,825
| +3% | +$178K | 0.11% | 157 |
|
|
2022
Q1 | $6.31M | Sell |
67,256
-1,140
| -2% | -$107K | 0.09% | 215 |
|
|
2021
Q4 | $5.83M | Sell |
68,396
-1,617
| -2% | -$138K | 0.07% | 287 |
|
|
2021
Q3 | $6.72M | Sell |
70,013
-445
| -0.6% | -$42.7K | 0.08% | 221 |
|
|
2021
Q2 | $6.86M | Buy |
70,458
+278
| +0.4% | +$27.1K | 0.08% | 241 |
|
|
2021
Q1 | $6.83M | Buy |
+70,180
| New | +$6.83M | 0.08% | 224 |
|